LAKE ZURICH, Ill., October 2, 2023 – Fresenius Kabi has been selected to exhibit its Ivenix Infusion System at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest provider-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine, Texas.
The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their product or service to supply chain and clinical leaders from Vizient’s provider customers and subject matter experts who serve on their supply councils. Each product or service will showcase how it improves clinical outcomes, enhances safety, or drives incremental improvements to health care delivery or business models.
The Ivenix Infusion System from Fresenius Kabi is designed to overcome deficiencies in legacy infusion pumps. The patented pumping technology in the Ivenix Infusion System delivers critical medications with flow that is continuously measured and controlled to help optimize fluid administration. The pump achieves accurate medication delivery with minimal impact from external conditions such as bag height, backpressure, and fluid viscosity, and it helps to prevent uncontrolled flow.
“The Ivenix Infusion System was designed to improve the patient experience and support efficient workflows for health care workers,” said Sue Niemeier, MHA, BSN, RN, vice president, clinical excellence at Fresenius Kabi USA. “We are excited to return to the Vizient Innovative Technology Exchange to demonstrate how the Ivenix Infusion System can help provide ease of use with infusion delivery.”
“The Exchange is an exciting part of the Vizient Innovative Technology Program, which results in Innovative Technology contract awards for the qualified products. This signals healthcare providers of a product’s unique qualities,” said Kelly Flaharty, senior director of contract services, Vizient. “With only a select number of suppliers invited to demonstrate their products, it’s an honor to be invited.”
The annual Innovative Technology Exchange is part of Vizient’s Innovative Technology Program that includes product review of supplier-submitted technologies by member-led councils and task forces. Since 2003, Vizient has reviewed over 1,600 product submissions as part of its Innovative Technology Program.
About Fresenius Kabi
Fresenius Kabi (www.fresenius-kabi.com/us) is a global health care company that specializes in injectable medicines, biosimilars, and technologies for infusion, transfusion, and clinical nutrition. The company’s products and services are used to help care for patients with critical and chronic conditions. The company’s U.S. headquarters is in Lake Zurich, Illinois. The company’s global headquarters is in Bad Homburg, Germany. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn.